We assessed the safety and immunogenicity of a fully liquid, DTPw-HepB-Hib combination vaccine (Quinvaxem) in comparison with separately administered DTPw-Hib and hepatitis B vaccines. Infants participating in this open-label, randomized, phase II study received a primary vaccination course using a...
IMMUNOGENICITY AND REACTOGENICITY IN INFANTS IMMUNISED WITH A NEW PENTAVALENT(DTwP-Hib-Hep B) VACCINE. |[utrif]| 1071IMMUNOGENICITY AND REACTOGENICITY IN INFANTS IMMUNISED WITH A NEW PENTAVALENT(DTwP-Hib-Hep B) VACCINE. |[utrif]| 1071Pediatric Research publishes original papers, invited reviews, a...
Hexaxim (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, recombinant hepatitis B virus surface antigen produced in the yeast using various immunization schedules wa...
内容提示: ADIS DRUG EVALUATIONDTaP-IPV-Hep B-Hib Vaccine (Hexaxim ? )A Review of its Use in Primary and Booster VaccinationPaul L. McCormackPublished online: 22 January 2013? Springer International Publishing Switzerland 2013Abstract Hexaxim ? (DTaP-IPV-Hep B-Hib) is a new,thiomersal-free, ...
Hexaxim() (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, recombinant hepatitis B virus surface antigen produced in the yeast Hansenula polymorpha, and Haemophilu...
liquid, ready-to-use, hexavalent vaccine approved in the EU since 2013 for primary and booster vac- cination in infants and toddlers from age 6 weeks against diphtheria, tetanus, pertussis, hepatitis B (HB), poliomyelitis, and invasive diseases caused by Haemophilus influen...
Vaccine Volume 27, Issue 31, 24 June 2009, Pages 4244 About ScienceDirect Contact and support Information for advertisers Terms and conditions Privacy policy Copyright © 2014 Elsevier B.V. except certain content provided by third parties. ScienceDirect® is a registered trademark of Else...
Hexaxim<sup class="a-plus-plus">®</sup> (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, recombinant hepatitis B virus surface antigen produced in the ye...
A compact pre-filled auto-disable injection (cPAD) presentation is being developed for the fully liquid pentavalent DTP-HepB-Hib vaccine. A cost analysis (CA) to compare this presentation with the presently used single-dose vial (SDV) and multi-dose vial (MDV) was conducted in Cambodia, Ghan...
Hexaxim® (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, recombinant hepatitis B virus surface antigen produced in the yeast Hansenula polymorpha, and Haemophil...